Laboratory Corporation of America Holdings (LH)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 12,901,700 15,811,000 15,621,000 15,510,300 15,632,000 13,745,500 14,941,300 15,859,000 16,120,900 16,554,600 16,388,100 15,316,200 13,978,500 12,442,100 11,474,500 11,587,400 11,554,800 11,388,900 11,291,700 11,276,300
Receivables US$ in thousands 1,905,800 1,948,100 1,893,900 2,334,000 2,211,500 2,153,300 2,205,000 2,226,400 2,247,500 2,335,400 2,210,100 2,323,500 2,479,800 2,095,200 1,661,000 1,482,200 1,543,900 1,617,200 1,576,100 1,563,000
Receivables turnover 6.77 8.12 8.25 6.65 7.07 6.38 6.78 7.12 7.17 7.09 7.42 6.59 5.64 5.94 6.91 7.82 7.48 7.04 7.16 7.21

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $12,901,700K ÷ $1,905,800K
= 6.77

The receivables turnover ratio for Laboratory Corp. Of America Holdings has shown some fluctuations over the past eight quarters. In Q4 2023, the receivables turnover was 5.79, indicating that the company collected its accounts receivable approximately 5.79 times during the quarter. This ratio increased from the previous quarter of 6.56 in Q3 2023 but is still lower than the peak of 6.90 in Q2 2023.

Compared to the same quarter the previous year (Q4 2022 at 4.93), the receivables turnover has improved, reflecting a more efficient collection process. Overall, the company's ability to convert its accounts receivable into cash has been relatively stable, with some variations in recent quarters. It is important for the company to continue monitoring this ratio to ensure timely collection of receivables and efficient management of its working capital.


Peer comparison

Dec 31, 2023

Company name
Symbol
Receivables turnover
Laboratory Corporation of America Holdings
LH
6.77
Fulgent Genetics Inc
FLGT
5.51
Quest Diagnostics Incorporated
DGX
7.52
RadNet Inc
RDNT
9.88